Results 141 to 150 of about 38,476 (212)

Dabigatran-based versus warfarin-based triple antithrombotic regimen with a 1-month intensification after coronary stenting in patients with nonvalvular atrial fibrillation (COACH-AF PCI). [PDF]

BMC Med
Liang M, Jin J, Zhao R, Li H, Chen S, Liu L, Xu P, Wang W, Cheng X, Chen X, Tao L, Zhang Q, Yang M, Zeng C, Li L, Zheng Y, Chen H, Guo J, Zhong Z, Bi Y, Cheng B, Zhou Y, Wang H, Zhang Y, Qiu M, Zhang Q, Zhang P, Zhang J, Wang Z, Li Y, Han Y.   +30 more
europepmc   +1 more source

Advances in emerging therapies 2009 [PDF]

, 2010
Lees, K.R., McArthur, K.
core   +1 more source

Is there a role for anticoagulation with dabigatran in S. aureus bacteremia? Protocol for the adjunctive treatment domain of the <i>Staphylococcus aureus</i> Network Adaptive Platform (SNAP) randomised controlled trial. [PDF]

BMJ Open
McDonald EG, Cheng MP, Davis JS, Goodman AL, Lawler PR, Marsh J, Mertz D, Paul M, Rodriguez-Baño J, Siegal DM, Tong SY, Walls G, Lee TC, SNAP Global Trial Steering Committee.   +13 more
europepmc   +1 more source

Economic Evaluation of Direct Oral Anticoagulants Versus Low-Molecular Weight Heparin for Cancer-Associated Thrombosis in a Thai University-Affiliated Hospital. [PDF]

J Clin Med
Chaiwattanakowit T, Pinitpracharome N, Dilokthornsakul W, Akrawikrai T, Dilokthornsakul P.   +4 more
europepmc   +1 more source

Dabigatran etexilate in the prevention of cardioembolic complications in patients with non-valvular atrial fibrillation

, 2014
IS Yavelov
openalex   +2 more sources

A Phase 1 Study to Assess the Effect of Fruquintinib on the Pharmacokinetics of P-gp and BCRP Substrates in Healthy Subjects. [PDF]

Clin Transl Sci
Gonzalez M, Yang Z, Schelman WR, Zhou X, Gupta N, Chien C.   +5 more
europepmc   +1 more source

A comparative study of the clinical benefits of rivaroxaban and dabigatran in patients with nonvalvular atrial fibrillation with high bleeding risk

Penghui Liu
openalex   +1 more source

Comparing the Efficacy and Safety of Different DOACs (Dabigatran, Rivaroxaban, Apixaban, Edoxaban) for Stroke Prevention in Atrial Fibrillation [PDF]

Dinesh Balamurugan, Collins Gilbert, Michael A�mann, Harsh Bansal   +3 more
openalex   +1 more source

Letter by David et al Regarding Article, “Periprocedural Bleeding and Thromboembolic Events With Dabigatran Compared With Warfarin: Results From the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) Randomized Trial” [PDF]

, 2013
Jean David, Vincent Piriou, Pierre Albaladejo   +2 more
openalex   +1 more source

Effect of Lesion Complexity and Clinical Risk Factors on the Efficacy and Safety of Dabigatran Dual Therapy Versus Warfarin Triple Therapy in Atrial Fibrillation After Percutaneous Coronary Intervention [PDF]

, 2020
Natalia Berry, Laura Mauri, Philippe Gabríel Steg, Deepak L. Bhatt, Stefan H. Hohnloser, Matias Nordaby, Corinna Miede, Takeshi Kimura, Gregory Y.H. Lip, Jonas Oldgren, Jurriën M. ten Berg, Christopher P. Cannon   +11 more
openalex   +1 more source